ReCor Medical, Inc. v. Medtronic Ireland Manufacturing Unlimited Co.
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 9 RECOR MEDICAL, INC., Case No. 22-cv-03072-TLT (TSH)
Plaintiff,
DISCOVERY ORDER
v. Re: Dkt. No. 122 MEDTRONIC IRELAND MANUFACTURING UNLIMITED CO., et al.,
Defendants.
16 We are here on Recor’s motion to compel concerning Symplicity treatment outcomes and Covidien’s OneShot renal denervation system. ECF No. 122. The Court held a hearing on March 28, 2025, and now issues the following order. A. Symplicity Treatment Outcomes Recor moves to compel documents and information concerning treatment outcomes for Medtronic’s Symplicity System, including its previous-generation Symplicity in 2014 and current- generation Symplicity Spyral in 2022. Specifically, Recor seeks: 1. RFP No. 66: “[d]ocuments that refer or relate to wholly or partially unsuccessful or ineffective treatments using Symplicity; failures of or complications in using the generator, catheter, or other components in connection with a treatment using…